Glyburide (glibenclamide)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Glyburide (glibenclamide), covering 2024-06-13 to 2024-08-26. Get the full timeline:
Most recent: Clinical Trial Update: Comparative Analysis of Cost-effectiveness Between Sulfonylureas and DPP4 Inhibitors in Combination With Metformin in Treatment of Type 2 Diabetic Patients : A Retrospective, Observational Study.